Paricalcitol
Who holds supplier records for Paricalcitol? 10 organisations hold a current record for Paricalcitol: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: United States (2), Netherlands (2), India (2) and Taiwan (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Paricalcitol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/paricalcitol
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Paricalcitol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Abbvie Inc.United States Company GMP cert on recordActive DMF 24315 · latest filing Nov 2010
- ALP PHARM BEIJING CO LTDActive DMF 21255 · latest filing Jan 2008
- CHONGQING HUAPONT PHARMACEUTICAL CO LTDActive DMF 28550 · latest filing Jul 2014
- DISHMAN NETHERLANDS BVNetherlandsActive DMF 25300 · latest filing Sept 2011
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 21880 · latest filing Aug 2008
- NANJING HERON PHARMACEUTICAL CO LTDActive DMF 38269 · latest filing Aug 2023
- Neuland Laboratories LimitedIndiaActive DMF 23895 · latest filing Jun 2010
- SAFC INCUnited StatesActive DMF 11340 · latest filing Feb 1995
- Sai Life Sciences LimitedIndiaActive DMF 26545 · latest filing Nov 2012
- TAPI NL BVNetherlandsActive DMF 20865 · latest filing Sept 2007
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Paricalcitol are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Japan · Inactive DMF 27145 · filed May 2013
Overview
Paricalcitol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200622).
Chemical identity
- IUPAC name
- trans-(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
- Canonical SMILES
- C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C
- InChIKey
- BPKAHTKRCLCHEA-UBFJEZKGSA-N
- Synonyms
- COMPOUND 49510, COMPOUND-49510, Paricalcitol, Zemplar, 19-Nor-1alpha,25-dihydroxyvitamin D2, 19-Nor-1,25-(OH)2D2, CHEBI:7931, paricalcitolum, RefChem:56862, H05BX02, Paracalcin, Paricalcitol [USAN]
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Vitamin D Analog; Vitamin D2 Analog; Vitamin D3 Analog
- Chemical structure
- Cholecalciferol; Ergocalciferols
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Paricalcitol?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Paricalcitol: Abbvie Inc. (United States), ALP PHARM BEIJING CO LTD, CHONGQING HUAPONT PHARMACEUTICAL CO LTD, DISHMAN NETHERLANDS BV (Netherlands), Formosa Laboratories, Inc. (Taiwan), NANJING HERON PHARMACEUTICAL CO LTD, Neuland Laboratories Limited (India) and SAFC INC (United States), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Paricalcitol Drug Master Files are active?
Abbvie Inc. (DMF 24315), ALP PHARM BEIJING CO LTD (DMF 21255), CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 28550), DISHMAN NETHERLANDS BV (DMF 25300), Formosa Laboratories, Inc. (DMF 21880), NANJING HERON PHARMACEUTICAL CO LTD (DMF 38269), Neuland Laboratories Limited (DMF 23895) and SAFC INC (DMF 11340) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Paricalcitol records mean?
1 organisation has only inactive Type II DMFs for Paricalcitol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Paricalcitol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Paricalcitol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.